- Diagnostics
- Friday, 05 Jun 2020
Japan to have coronavirus vaccines in use by June 2021
Drugmakers around the world are scrambling to develop a treatment or vaccine for COVID-19, the respiratory disease caused by the highly infectious new coronavirus which has so far killed nearly 400,000 people worldwide.
“We will be securing production facilities in parallel with expedited vaccine development,” Japan’s Health Minister Katsunobu Kato told reporters as he outlined plans to bring vaccines into use by the end of the first half of 2021.
Usually, plants for actual vaccine production are arranged only after the successful completion of development.
The Japanese government has earmarked 146 billion yen ($1.34 billion) for vaccine production and distribution in the second extra budget that Prime Minister Shinzo Abe’s cabinet approved last month.
Japanese pharmaceutical firms developing coronavirus vaccines include Shionogi & Co and AnGes Inc.
Related Industry Updates
Quest Diagnostics Begins to Perform COVID-19 Antibody Testing
Apr 22, 2020
DERMALOG Provides the World's First Biometric Border Control System With Integrated Fever Detection
Feb 13, 2020
Mobile COVID-19 testing set for Bolivar, Yazoo, Montgomery, Perry and Claiborne counties
Apr 20, 2020
Yuyu Pharma will export COVID-19 test sets from SD BIOSENSOR to the world market
Jun 18, 2020
Natera Launches Zenith Genomics for Rare Disease in US Healthcare
Mar 13, 2026
FDA Approves Diffusion-Weighted Images for Elekta Unity, Expanding Options for Assessment During Therapy
Dec 16, 2019
Merck KGaA says profit could slip as fertility treatments shunned
May 14, 2020
Follow us on
